药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Metacycline
Triclabendazole
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Triclabendazole.
Metacycline
Temefos
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Temefos.
Metacycline
Tetrahydropalmatine
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Tetrahydropalmatine.
Metacycline
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Prulifloxacin.
Metacycline
CUDC-907
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with CUDC-907.
Metacycline
Anisodamine
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Anisodamine.
Metacycline
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Pazufloxacin.
Metacycline
Rupatadine
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Rupatadine.
Metacycline
Bilastine
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Bilastine.
Metacycline
Difloxacin
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Difloxacin.
Metacycline
Sarafloxacin
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Sarafloxacin.
Metacycline
Phosmet
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Phosmet.
Metacycline
Orbifloxacin
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Orbifloxacin.
Metacycline
Fenthion
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Fenthion.
Metacycline
Famphur
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Famphur.
Metacycline
Dichlorvos
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Dichlorvos.
Metacycline
Coumaphos
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Coumaphos.
Metacycline
Niguldipine
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Niguldipine.
Metacycline
Lacidipine
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Lacidipine.
Metacycline
Efonidipine
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Efonidipine.